Friday, Jan 2: Shares of Dr Reddy’s Laboratories slipped nearly 2% in Friday’s session after JPMorgan reiterated its ‘Underweight’ rating on the stock and set a target price of Rs 1,170, citing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results